Bringing the fundamentals into focus…
Back to BioCryst Pharmaceuticals, Inc.
How BioCryst Pharmaceuticals, Inc. stacks up
BCRX · against 386 other Healthcare companies of similar size
Overall
32/ 100
Near the bottom of its peers.
Ranked #321 of 387 · scores higher than 16% of peers
Bars: peers in each 10-point band of the overall score53 peers with an overall score of 30–39, including BCRX · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around BCRX| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 2 | 15.6B DKK (≈$2.3B) | 96 | 96 | 99 | 96 | 0 / 2 | |
| 4 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 5 | 2.29T KRW (≈$1.6B) | 88 | 83 | 90 | 96 | 0 / 2 | |
| 315 | 1.3B USD | 33 | 8 | 95 | 12 | 2 / 2 | |
| 315 | 3.0B CHF (≈$3.5B) | 33 | 32 | 14 | 44 | 1 / 2 | |
| 321 | 9.3B CNY (≈$1.3B) | 32 | 0 | 7 | 35 | 0 / 2 | |
| 321 | 9.1B CNY (≈$1.3B) | 32 | 29 | 13 | 34 | 1 / 2 | |
| 321 | 2.2B USD | 32 | 8 | 89 | 22 | 2 / 2 | |
| 321 | 2.5B USD | 32 | 50 | 34 | 38 | 2 / 2 | |
| 321 | 1.5B USD | 32 | 8 | 93 | 19 | 2 / 2 | |
| 321 | 2.6B USD | 32 | 39 | 36 | 36 | 2 / 2 | |
| 321 | 1.9B USD | 32 | 8 | 94 | 17 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score